Exosens Stock Defies CAC 40 with a Soaring +102% Yearly Increase

Exosens Shares Rise Following Deutsche Bank's Price Target Increase

Exosens stock is up 2.59% at 65.30 euros this Wednesday morning, after closing at 63.65 euros the previous day. This rebound occurs as Deutsche Bank raised its price target from 55 to 60 euros, while maintaining its 'hold' recommendation. However, the new target remains 8.1% below the current price, reflecting the German institution's cautious view on the company's valuation. This movement is part of a contrasting sectoral context in Europe: Airbus is down 0.51% and Safran is down 1.70% in the session, while in the United States, RTX Corporation closed up 0.70% but Lockheed Martin dropped 1.31%. The release of Exosens's first quarter 2026 results, scheduled for April 27, will be the next catalyst for the stock.

Technical Analysis Indicates a Medium-Term Bullish Trend

From a technical standpoint, the price of 65.30 euros is above the 50-day moving average of 61.68 euros, confirming a medium-term bullish trend. The gap with the 200-day moving average, set at 48.93 euros, illustrates the extent of the progress made over a year, with performance reaching 102.8% over twelve months. The RSI, at 51, signals a balance between buying and selling pressures, with no overbought or oversold conditions. The stock oscillates in the median zone of its Bollinger Bands, with the upper bound at 73.61 euros and the lower bound at 55.57 euros. The next identifiable resistance threshold is positioned at 72.90 euros, while the major support is at 57.50 euros. Over the last three months, the progression reaches 13.57%, even though the weekly performance shows a slight decline of 0.99%. The monthly volatility, measured at 13.52%, indicates moderate variation amplitudes at this stage.